Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy of the peptide on reducing body fat
- Conditions
- one
- Registration Number
- JPRN-UMIN000053658
- Lead Sponsor
- Yamaguchi Health Lab
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Not provided
1) Subjects who have serious disease or who have history of serious disease 2) Subjects who regularly undertake medications that affect obesity, hyperlipidemia or lipid metabolism 3) Subjects who cannot stop taking health foods or supplements that affect obesity, hyperlipidemia or lipid metabolism 4) Heavy smokers (more than 21 cigarettes/day) 5) Subjects who have excessive alcoholic drinks (more than 60 g/day of alcohol) 6) Subjects with serious medication allergy or food allergy 7) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study 8) Subjects who are currently participating, or intend to participate during this study period, in other trials involving the testing of other foods or the use of drugs or the application of cosmetics and drugs 9) Subjects who are considered to be inappropriate for this study by the principal investigator or the examination doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body fat
- Secondary Outcome Measures
Name Time Method Body weight, BMI, Waist circumference